1620 Investment Advisors »

Amphastar Pharmaceuticals shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $115k 2.4k 48.53
2024-06-30 $93k 2.3k 40.00

More positions owned by 1620 Investment Advisors

SPDR Portfolio Intrmdt Term Corp Bd ETF Etf (SPIB)
iShares 7-10 Year Treasury Bond ETF Etf (IEF)
SPDR MSCI EAFE StrategicFactors ETF Etf (QEFA)
SPDR S&P 600 Small Cap ETF Etf
Tri Continental Corporation Etf (TY)
SPDR Ptf Short-Term Treasury ETF Etf (SPTS)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
TJX Companies (TJX)
iShares Short Term Ntnl Muni Bond ETF Etf (SUB)
iShares Short-Term Corporate Bond ETF Etf (IGSB)
Microsoft Corporation (MSFT)
Freedom 100 Emerging Markets ETF Etf (FRDM)
Schwab U.S. TIPS ETF Etf (SCHP)
SPDR Doubleline Total Return Tactical ETF Etf (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding Amphastar Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
TD Asset Management
Federated Investors
Neuberger Berman Group
State Street Corporation
Hanna Zanoni
Epoch Investment Partners
Dimensional Fund Advisors
Geode Capital Management
American Century Companies
Morgan Stanley
Northern Trust
T. Rowe Price Associates

View all funds holding Amphastar Pharmaceuticals